![Dennis Yamashita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Yamashita
No open positions remaining
Profile
Dennis Yamashita formerly worked at Oncology, Inc., as Director, GlaxoSmithKline, Inc., as Principal, Trevena, Inc., as Vice President & Head-Chemistry, Oric Pharmaceuticals, Inc., as Vice President-Drug Discovery from 2017 to 2018, Axial Therapeutics, Inc., as Vice President-Medical Chemistry from 2018 to 2020, Cambrian BioPharma, Inc., as Vice President-Chemistry from 2020 to 2023, and TuHURA Biosciences, Inc., as Chief Scientific Officer in 2024.
Dr. Yamashita received his undergraduate degree in 1986 from Massachusetts Institute of Technology and doctorate degree in 1991 from Yale University.
Former positions of Dennis Yamashita
| Companies | Position | End |
|---|---|---|
Cambrian BioPharma, Inc.
 Cambrian BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company focused on treating and preventing chronic diseases of aging | Corporate Officer/Principal | 30/11/2023 |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Corporate Officer/Principal | 31/08/2020 |
| ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30/04/2018 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Training of Dennis Yamashita
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Oncology, Inc.
 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides oncology treatment information | Commercial Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company focused on treating and preventing chronic diseases of aging | Health Technology |
- Stock Market
- Insiders
- Dennis Yamashita
